Amino‐terminal propeptide of C‐type natriuretic peptide (NTproCNP) predicts height velocity in healthy children
- 21 March 2012
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 77 (3) , 416-422
Abstract
Summary: Objective: C‐type natriuretic peptide (CNP) is a paracrine regulatory factor of the growth plate and plays a key role in endochondral growth. Its amino‐terminal propeptide (NTproCNP) is an equimolar product of CNP biosynthesis and is easily measured in plasma. Preliminary studies suggest that NTproCNP levels correlate with height velocity in sheep and children. The objectives of the study were to correlate NTproCNP levels with height velocity and to define the reference range for plasma CNP and NTproCNP across childhood.Design: This was a prospective, cross‐sectional, observational study of healthy children.Patients: Participants were 258 healthy children between 2 months and 20 years of age.Measurements: Anthropometrics were obtained and CNP and NTproCNP levels were determined by radioimmunoassay.Results: For both sexes, CNP and NTproCNP levels were high in infancy, lower in early childhood, rising during puberty, then falling to low adult levels. Levels of NTproCNP peaked at 14·1 years in boys and 11·9 years in girls, coincident with the age of peak height velocity. Levels of NTproCNP varied with pubertal status, peaking at genital Tanner stage IV in boys and III in girls. There was a highly significant correlation between NTproCNP and height velocity.Conclusions: C‐type natriuretic peptide plays an integral role in endochondral growth. We show here that CNP synthesis (as measured by NTproCNP levels in plasma) is closely related to linear growth in healthy children at all ages. We propose NTproCNP as a biomarker of linear growth.Keywords
This publication has 32 references indexed in Scilit:
- Plasma C‐type natriuretic peptide forms and thyroid status in prepubertal children with acquired thyroid diseaseClinical Endocrinology, 2011
- Regional Release and Clearance of C-Type Natriuretic Peptides in the Human Circulation and Relation to Cardiac FunctionHypertension, 2009
- Systemic Administration of C-Type Natriuretic Peptide as a Novel Therapeutic Strategy for Skeletal DysplasiasEndocrinology, 2009
- Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocationHuman Mutation, 2007
- The relationships between pubertal development, IGF-1 axis, and bone formation in healthy adolescentsJournal of Bone and Mineral Metabolism, 2004
- Mutations in the Transmembrane Natriuretic Peptide Receptor NPR-B Impair Skeletal Growth and Cause Acromesomelic Dysplasia, Type MaroteauxThe American Journal of Human Genetics, 2004
- Furin-mediated Processing of Pro-C-type Natriuretic PeptideJournal of Biological Chemistry, 2003
- C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell lineJournal of Bone and Mineral Metabolism, 2002
- Identification of Amino-Terminal Pro-C-Type Natriuretic Peptide in Human PlasmaBiochemical and Biophysical Research Communications, 2001
- Clinical longitudinal standards for height and height velocity for North American childrenThe Journal of Pediatrics, 1985